Interventions That Boost Mood Cut Inflammation With IBD
By Lori Solomon HealthDay Reporter
WEDNESDAY, Jan. 31, 2024 -- Interventions that improve mood can reduce levels of inflammation in people with inflammatory bowel disease (IBD), according to a review published online Jan. 24 in eBioMedicine.
Natasha Seaton, from King's College London, and colleagues conducted a systematic literature review and meta-analysis to determine whether interventions targeting mood outcomes (e.g., depression, anxiety, and stress) impact inflammation levels in IBD.
Based on 28 randomized controlled trials (1,789 participants), the researchers found that interventions demonstrated small, statistically significant effects on biomarkers (−0.35) and medium effects on mood outcomes (−0.50). There was no evidence of substantive heterogeneity or publication bias. Interventions had small effects for improved fecal calprotectin (−0.19) and C-reactive protein (−0.29). Compared with exercise or antidepressants, effect sizes were larger for psychological therapy interventions and when there was an effect (standardized mean differences ≥0.2) on mood.
"This adds to the growing body of research demonstrating the role of inflammation in mental health and suggests that interventions working to improve mood could also have direct physical effects on levels of inflammation," coauthor Valeria Mondelli, also from King's College, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-02-01 00:15
Read more
- Novartis Scemblix Granted FDA Accelerated Approval in Newly Diagnosed CML
- Boarding Admitted Stroke Patients in Emergency Department Financially Costly
- NIH Clinical Trial Will Test Precision Medicine Treatments for Myeloid Cancers
- Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
- Costs for MS, Parkinson's and Alzheimer's Meds Keep Rising
- AAO: Corneal Toxicity Reported With Mirvetuximab Soravtansine
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions